MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript

MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript March 12, 2024

MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. MaxCyte, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day and thank you for standing by. Welcome to the MaxCyte Fourth Quarter Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded....